UK Biotech Financing Holds Up Despite Woodford and Brexit

Neil Woodford’s Fall From Grace And Brexit Dragged On An Otherwise Buoyant Sector

River_Thames
UK biotech gave a strong showing in 2019, but still isn't as well capitalised as US counterparts
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip